Patents by Inventor José Luís de Almeida

José Luís de Almeida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE
    Publication number: 20230129254
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: May 19, 2022
    Publication date: April 27, 2023
    Inventors: José Luis de Almeida, Patrício Manuel Vieira Araújo Soares da Silva, Jose Luis de Almeida
  • Methods of treatment of partial onset seizures using eslicarbazepine acetate
    Patent number: 11364247
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: June 21, 2022
    Assignee: BIAL-PORTELA & CA S.A.
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE
    Publication number: 20210154203
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: July 2, 2020
    Publication date: May 27, 2021
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • Methods of treatment of partial onset seizures using eslicarbazepine acetate
    Patent number: 10702536
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: July 7, 2020
    Assignee: BIAL-PORTELA & CA S.A.
    Inventors: José Luis de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • Methods of treatment of partial onset seizures using eslicarbazepine acetate
    Patent number: 10695354
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: June 30, 2020
    Assignee: Bial-Portela & CA S.A.
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • Methods of treatment of partial onset seizures using eslicarbazepine acetate
    Patent number: 10675287
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: June 9, 2020
    Assignee: Bial-Portela & CA S.A.
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE
    Publication number: 20190307765
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 10, 2019
    Inventors: Jose Luis de Almeida, Patricio Manuel Vieira Araújo Soares da Silva
  • METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE
    Publication number: 20190307764
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 10, 2019
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
  • METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE.
    Publication number: 20170143736
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: February 1, 2017
    Publication date: May 25, 2017
    Applicant: BIAL-PORTELA & CA S.A
    Inventors: José Luis de ALMEIDA, Patricio Manuel Vieria Araujo Soares Da Silva
  • METHODS OF PREPARING PHARMACEUTICAL COMPOSITIONS COMPRISING ESLICARBAZEPINE ACETATE AND METHODS OF USE
    Publication number: 20140288058
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: February 21, 2014
    Publication date: September 25, 2014
    Applicant: Bial-Portela & CA. S.A.
    Inventors: Jose' Luis de Almeida, Patricio Manuel Vieria Arauj Soares da Silva
  • METHODS OF PREPARING PHARMACEUTICAL COMPOSITIONS COMPRISING ESLICARBAZEPINE ACETATE AND METHODS OF USE
    Publication number: 20110319388
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: January 31, 2011
    Publication date: December 29, 2011
    Inventors: José Luís de Almeida, Patrício Manuel Vieira Araújo Soares Da Silva
  • ADMINISTRATION REGIME FOR NITROCATECHOLS
    Publication number: 20110301204
    Abstract: The present invention relates to novel dosage regimens for compounds of formula I: where the substituents are as defined in the specification.
    Type: Application
    Filed: July 29, 2009
    Publication date: December 8, 2011
    Applicant: BIAL - PORTELA & CA., S.A.
    Inventors: José Luis de Almeida, David Alexander Learmonth, Patricio Manuel Vieira Araújo Soares da Silva
  • Methods of Preparing Pharmaceutical Compositions Comprising Eslicarbazepine Acetate and Methods of Use
    Publication number: 20100222327
    Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
    Type: Application
    Filed: August 4, 2009
    Publication date: September 2, 2010
    Inventors: José Luis de Almeida, Patrício Manuel Vieira Araújo Soares Da Silva